This inventor holds 5 USPTO granted patents. Top assignees: Janssen Pharmaceutica Nv, Janssen Pharmaceutica. Active years: 2001-2004.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2001-2004
Title: The Innovative Contributions of Marc René De Jonge
Introduction
Marc René De Jonge is a notable inventor based in Tilburg, Netherlands, recognized for his significant contributions to the field of chemistry. With an impressive record of five patents, his work primarily focuses on the development of triazine derivatives, showcasing his expertise and innovative spirit.
Latest Patents
De Jonge's latest patents include advancements in trisubstituted and 2,4-disubstituted triazine derivatives. These patents reflect his commitment to enhancing chemical compounds and their applications in various industries, particularly pharmaceuticals.
Career Highlights
Throughout his professional journey, Marc René De Jonge has made a substantial impact while working for esteemed companies such as Janssen Pharmaceutica NV and Janssen Pharmaceutica. His tenure at these organizations has positioned him as a leading figure in the pharmaceutical industry, contributing to the development of breakthrough therapeutic solutions.
Collaborations
Collaboration has been a key aspect of De Jonge's success. Working alongside talented colleagues such as Bart L De Corte and Jan Heeres, he has been involved in pioneering projects that push the boundaries of innovation in pharmaceutical chemistry.
Conclusion
Marc René De Jonge continues to be a significant player in the realm of chemistry and pharmaceuticals. His patents and collaborations underscore his dedication to advancing scientific knowledge and developing innovative solutions that address critical challenges in the industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile